Arcturus Therapeutics Holdings (ARCT) Change in Receivables: 2018-2025
Historic Change in Receivables for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to -$9.3 million.
- Arcturus Therapeutics Holdings' Change in Receivables fell 251.34% to -$9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.2 million, marking a year-over-year decrease of 177.37%. This contributed to the annual value of -$28.1 million for FY2024, which is 195.87% down from last year.
- Per Arcturus Therapeutics Holdings' latest filing, its Change in Receivables stood at -$9.3 million for Q3 2025, which was down 451.56% from $2.6 million recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Change in Receivables ranged from a high of $89.7 million in Q1 2023 and a low of -$89.7 million during Q2 2023.
- Moreover, its 3-year median value for Change in Receivables was -$3.0 million (2024), whereas its average is $471,545.
- Examining YoY changes over the last 5 years, Arcturus Therapeutics Holdings' Change in Receivables showed a top increase of 27,591.05% in 2023 and a maximum decrease of 6,110.80% in 2023.
- Arcturus Therapeutics Holdings' Change in Receivables (Quarterly) stood at $1.4 million in 2021, then crashed by 46.75% to $720,000 in 2022, then slumped by 955.00% to -$6.2 million in 2023, then tumbled by 326.01% to -$26.2 million in 2024, then tumbled by 251.34% to -$9.3 million in 2025.
- Its Change in Receivables was -$9.3 million in Q3 2025, compared to $2.6 million in Q2 2025 and $10.6 million in Q1 2025.